Variant report
Variant | nsv828170 |
---|---|
Chromosome Location | chr18:7135584-7146632 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs540508083 | chr18:7135615-7135616 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs1848893 | chr18:7135632-7135633 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
3 | rs532156926 | chr18:7135708-7135709 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs61437164 | chr18:7135709-7135710 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs562581264 | chr18:7135724-7135725 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs8091736 | chr18:7135763-7135764 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
7 | rs55663518 | chr18:7135797-7135798 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
8 | rs62082795 | chr18:7135804-7135805 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs567838692 | chr18:7135830-7135831 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs536576701 | chr18:7135860-7135861 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs8091856 | chr18:7135877-7135878 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs150654683 | chr18:7135924-7135925 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs538662715 | chr18:7135966-7135967 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs539890646 | chr18:7136001-7136002 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs549759240 | chr18:7136004-7136005 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs58186971 | chr18:7136018-7136019 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs575334489 | chr18:7136140-7136141 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs537942630 | chr18:7136148-7136149 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs193241968 | chr18:7136151-7136152 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs138024203 | chr18:7136161-7136162 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs6506477 | chr18:7136174-7136175 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
22 | rs139906226 | chr18:7136198-7136199 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs560414245 | chr18:7136227-7136228 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs185682318 | chr18:7136229-7136230 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs149168471 | chr18:7136269-7136270 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs6506478 | chr18:7136354-7136355 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
27 | rs6506479 | chr18:7136389-7136390 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
28 | rs75309586 | chr18:7136399-7136400 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs541269427 | chr18:7136447-7136448 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs548289919 | chr18:7136458-7136459 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs561351661 | chr18:7136463-7136464 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs559506618 | chr18:7136480-7136481 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs534802861 | chr18:7136488-7136489 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs530338045 | chr18:7136491-7136492 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs149842862 | chr18:7136492-7136493 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs145883875 | chr18:7136506-7136507 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs374078591 | chr18:7136526-7136527 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs543484637 | chr18:7136560-7136561 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs190143645 | chr18:7136565-7136566 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs13381962 | chr18:7136569-7136570 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
41 | rs71354533 | chr18:7136591-7136592 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs63285761 | chr18:7136604-7136605 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs577015547 | chr18:7136618-7136619 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs545553025 | chr18:7136622-7136623 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs181531847 | chr18:7136638-7136639 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs199582276 | chr18:7136642-7136643 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs555070574 | chr18:7136649-7136650 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs7240402 | chr18:7136650-7136651 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
49 | rs7240403 | chr18:7136656-7136657 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
50 | rs375494547 | chr18:7136667-7136668 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Heart disease | 21282601 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Melanoma | 18172304 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Intellectual disability | 22102821 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Seminomas | 18059402 | CNVD |
Chronic lymphocytic leukemia | 18922857 | CNVD |
Kartagener syndrome | 16639409 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Cancer | 21183584 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Colorectal cancer | 19150955 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Chordoma | 21602918 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Cancer | 21637783 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Trisomy 18 syndrome | 17576883 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 21785460 | CNVD |
Autism | 20808228 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Barrett''s syndrome | 19417022 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Developmental delay | 21147756 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Breast cancer | 21364760 | CNVD |
Breast cancer | 21858162 | CNVD |
small cell lung cancer | 20016488 | CNVD |
abnormal development | 18461090 | CNVD |
Cutaneous T-cell lymphoma | 21881587 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Retinoblastoma | 21504564 | CNVD |
Breast cancer | 17133270 | CNVD |
Glioblastoma multiforme | 21922591 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Burkitt''s lymphoma | 20823134 | CNVD |
Acute myeloid leukemia | 17377590 | CNVD |
Non-syndromic sensorineural hearing loss | 21293372 | CNVD |
Non-syndromic sensorineural hearing loss | 19587683 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr18:7135000-7136400 | Enhancers | Hela-S3 | cervix |
2 | chr18:7135400-7135600 | Enhancers | hESC Derived CD56+ Mesoderm Cultured Cells | ES cell derived |
3 | chr18:7136400-7136600 | Enhancers | Placenta | Placenta |
4 | chr18:7136400-7138000 | Weak transcription | Hela-S3 | cervix |
5 | chr18:7138000-7138800 | Enhancers | Hela-S3 | cervix |
6 | chr18:7143400-7143600 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
7 | chr18:7143600-7146200 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
8 | chr18:7145800-7146400 | Enhancers | Foreskin Keratinocyte Primary Cells skin02 | Skin |
9 | chr18:7146000-7146400 | Enhancers | hESC Derived CD56+ Mesoderm Cultured Cells | ES cell derived |
10 | chr18:7146000-7146400 | Enhancers | Breast Myoepithelial Primary Cells | Breast |
11 | chr18:7146000-7146400 | Enhancers | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
12 | chr18:7146000-7146400 | Enhancers | Foreskin Keratinocyte Primary Cells skin03 | Skin |
13 | chr18:7146000-7146400 | Enhancers | HMEC | breast |
14 | chr18:7146000-7146600 | Enhancers | NHEK | skin |
15 | chr18:7146200-7146400 | Enhancers | ES-WA7 Cell Line | embryonic stem cell |
16 | chr18:7146200-7146400 | Enhancers | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
17 | chr18:7146200-7147400 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
18 | chr18:7146200-7148200 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
19 | chr18:7146400-7147400 | Weak transcription | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
20 | chr18:7146600-7147600 | Weak transcription | ES-WA7 Cell Line | embryonic stem cell |